| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accuracy of package inserts of SARS-CoV-2 rapid antigen tests: a secondary analysis of manufacturer versus systematic review data
|
Bigio, Jacob
|
|
|
|
11 |
p. e875-e882
|
artikel
|
| 2 |
Africa's post-pandemic vaccination landscape
|
Adepoju, Paul
|
|
|
|
11 |
p. e862
|
artikel
|
| 3 |
AMR is more complicated than a lack of drugs
|
The Lancet Microbe,
|
|
|
|
11 |
p. e851
|
artikel
|
| 4 |
Call for emergency action to limit global temperature increases, restore biodiversity, and protect health
|
Atwoli, Lukoye
|
|
|
|
11 |
p. e567-e569
|
artikel
|
| 5 |
Causal discovery for the microbiome
|
Corander, Jukka
|
|
|
|
11 |
p. e881-e887
|
artikel
|
| 6 |
Changes in infant microbiome linked to prenatal opioids
|
Nelson, Roxanne
|
|
|
|
11 |
p. e812
|
artikel
|
| 7 |
Closing Africa's wide COVID-19 testing and vaccination gaps
|
Adepoju, Paul
|
|
|
|
11 |
p. e573
|
artikel
|
| 8 |
Correction to Lancet Microbe 2023; 4: e683–91
|
|
|
|
|
11 |
p. e860
|
artikel
|
| 9 |
Correction to Lancet Microbe 2021; published online Oct 7. https://doi.org/10.1016/S2666-5247(21)00182-8
|
|
|
|
|
11 |
p. e572
|
artikel
|
| 10 |
COVID-19: stewardship of diagnostic tests for bacterial co-infection
|
Williams, Tom G S
|
|
|
|
11 |
p. e570
|
artikel
|
| 11 |
Determinants of passive antibody efficacy in SARS-CoV-2 infection: a systematic review and meta-analysis
|
Stadler, Eva
|
|
|
|
11 |
p. e883-e892
|
artikel
|
| 12 |
Discovery and validation of a three-gene signature to distinguish COVID-19 and other viral infections in emergency infectious disease presentations: a case-control and observational cohort study
|
Li, Ho Kwong
|
|
|
|
11 |
p. e594-e603
|
artikel
|
| 13 |
Distribution and spread of the mobilised RND efflux pump gene cluster tmexCD-toprJ in clinical Gram-negative bacteria: a molecular epidemiological study
|
Dong, Ning
|
|
|
|
11 |
p. e846-e856
|
artikel
|
| 14 |
Do Prevotella copri and Blastocystis promote euglycaemia?
|
Janket, Sok-Ja
|
|
|
|
11 |
p. e565-e566
|
artikel
|
| 15 |
Economic evaluations of whole-genome sequencing for pathogen identification in public health surveillance and health-care-associated infections: a systematic review
|
Tran, My
|
|
|
|
11 |
p. e953-e962
|
artikel
|
| 16 |
Effect of amoxicillin on the gut microbiome of children with severe acute malnutrition in Madarounfa, Niger: a retrospective metagenomic analysis of a placebo-controlled trial
|
Schwartz, Drew J
|
|
|
|
11 |
p. e931-e942
|
artikel
|
| 17 |
Effect of seven anti-tuberculosis treatment regimens on sputum microbiome: a retrospective analysis of the HIGHRIF study 2 and PanACEA MAMS-TB clinical trials
|
Musisi, Emmanuel
|
|
|
|
11 |
p. e913-e922
|
artikel
|
| 18 |
Embracing the monsters: moving from infection control to microbial management
|
Kirchhelle, Claas
|
|
|
|
11 |
p. e806-e807
|
artikel
|
| 19 |
Emergence of Shiga toxin-producing Escherichia coli O157:H7 in paediatric patients in Shenzhen, China
|
Patil, Sandip
|
|
|
|
11 |
p. e809
|
artikel
|
| 20 |
Epidemiological analysis of Legionnaires' disease in Scotland: a genomic study
|
Gorzynski, Jamie
|
|
|
|
11 |
p. e835-e845
|
artikel
|
| 21 |
Estimating clinical SARS-CoV-2 infectiousness in Vero E6 and primary airway epithelial cells
|
Essaidi-Laziosi, Manel
|
|
|
|
11 |
p. e571
|
artikel
|
| 22 |
Genetic variants and their association with phenotypic resistance to bedaquiline in Mycobacterium tuberculosis: a systematic review and individual isolate data analysis
|
Ismail, Nabila
|
|
|
|
11 |
p. e604-e616
|
artikel
|
| 23 |
Genomic characterisation of multidrug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two intensive care units in Hanoi, Viet Nam: a prospective observational cohort study
|
Roberts, Leah W
|
|
|
|
11 |
p. e857-e866
|
artikel
|
| 24 |
Highlights from ICOPA 2022
|
Frias, Liesbeth
|
|
|
|
11 |
p. e813
|
artikel
|
| 25 |
Human infection of avian influenza A H3N8 virus and the viral origins: a descriptive study
|
Yang, Rengui
|
|
|
|
11 |
p. e824-e834
|
artikel
|
| 26 |
Immunogenicity and safety of AZD2816, a beta (B.1.351) variant COVID-19 vaccine, and AZD1222 (ChAdOx1 nCoV-19) as third-dose boosters for previously vaccinated adults: a multicentre, randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study in the UK and Poland
|
Ramasamy, Maheshi N
|
|
|
|
11 |
p. e863-e874
|
artikel
|
| 27 |
Immunomics-guided discovery of serum and urine antibodies for diagnosing urogenital schistosomiasis: a biomarker identification study
|
Pearson, Mark S
|
|
|
|
11 |
p. e617-e626
|
artikel
|
| 28 |
Investment in biosafety and biosecurity: the need for a risk-based approach and systematic reporting of laboratory accidents to mitigate laboratory-acquired infections and pathogen escapes
|
Blacksell, Stuart D
|
|
|
|
11 |
p. e854-e855
|
artikel
|
| 29 |
Is it possible to generalise superspreading individuals or events of SARS-CoV-2?
|
Shrestha, Sunil
|
|
|
|
11 |
p. e858
|
artikel
|
| 30 |
Is it possible to generalise superspreading individuals or events of SARS-CoV-2? – Authors' reply
|
Zhou, Jie
|
|
|
|
11 |
p. e859
|
artikel
|
| 31 |
Key parameters for genomics-based real-time detection and tracking of multidrug-resistant bacteria: a systematic analysis
|
Gorrie, Claire L
|
|
|
|
11 |
p. e575-e583
|
artikel
|
| 32 |
Life science research and the need for vigilance
|
The Lancet Microbe,
|
|
|
|
11 |
p. e803
|
artikel
|
| 33 |
Low prevalence of asymptomatic mpox in populations at high risk
|
Hampel, Benjamin
|
|
|
|
11 |
p. e856
|
artikel
|
| 34 |
Malaria eliminated in Belize
|
Venkatesan, Priya
|
|
|
|
11 |
p. e861
|
artikel
|
| 35 |
New threats to visceral leishmaniasis control
|
Makoni, Munyaradzi
|
|
|
|
11 |
p. e574
|
artikel
|
| 36 |
NIMble innovation—a networked model for public antibiotic trials
|
Glover, Rebecca E
|
|
|
|
11 |
p. e637-e644
|
artikel
|
| 37 |
Persistence of immunity following a single dose of inactivated poliovirus vaccine: a phase 4, open label, non-randomised clinical trial
|
Sharma, Arun K
|
|
|
|
11 |
p. e923-e930
|
artikel
|
| 38 |
Population structure and antimicrobial resistance among Klebsiella isolates sampled from human, animal, and environmental sources in Ghana: a cross-sectional genomic One Health study
|
Calland, Jessica K
|
|
|
|
11 |
p. e943-e952
|
artikel
|
| 39 |
Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa: a retrospective molecular epidemiology study
|
Cox, Helen
|
|
|
|
11 |
p. e584-e593
|
artikel
|
| 40 |
“Recent gains reversed, targets off track”
|
The Lancet Microbe,
|
|
|
|
11 |
p. e564
|
artikel
|
| 41 |
Severity of influenza-associated hospitalisations by influenza virus type and subtype in the USA, 2010–19: a repeated cross-sectional study
|
Sumner, Kelsey M
|
|
|
|
11 |
p. e903-e912
|
artikel
|
| 42 |
Spillover infection of common animal coronaviruses to humans
|
Zhai, Shao-Lun
|
|
|
|
11 |
p. e808
|
artikel
|
| 43 |
The association between early-life gut microbiota and childhood respiratory diseases: a systematic review
|
Alcazar, Cristina Garcia-Maurino
|
|
|
|
11 |
p. e867-e880
|
artikel
|
| 44 |
The emergence of tet(X) variants highlight challenges for the global genomic surveillance of tigecycline resistance
|
Rueda Furlan, João Pedro
|
|
|
|
11 |
p. e857
|
artikel
|
| 45 |
The time is now: a call to contain H9N2 avian influenza viruses
|
Bi, Yuhai
|
|
|
|
11 |
p. e804-e805
|
artikel
|
| 46 |
Transmission of SARS-CoV-2 by children to contacts in schools and households: a prospective cohort and environmental sampling study in London
|
Cordery, Rebecca
|
|
|
|
11 |
p. e814-e823
|
artikel
|
| 47 |
Transplacental transfer efficiency of maternal antibodies against influenza A(H1N1)pdm09 virus and dynamics of naturally acquired antibodies in Chinese children: a longitudinal, paired mother–neonate cohort study
|
Li, Mei
|
|
|
|
11 |
p. e893-e902
|
artikel
|
| 48 |
WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017–18: a retrospective observational study
|
Unemo, Magnus
|
|
|
|
11 |
p. e627-e636
|
artikel
|
| 49 |
Why is there expanding community transmission of monkeypox in 2022?
|
Marty, Aileen M
|
|
|
|
11 |
p. e810-e811
|
artikel
|
| 50 |
Why is the UK subscription model for antibiotics considered successful?
|
Glover, Rebecca E
|
|
|
|
11 |
p. e852-e853
|
artikel
|
Tijdschrift beschrijving